The first test was administered in April 2022, and the last was in August 2023
2 Methodology We conducted a structured literature search using PubMed, Web of Science, and Scopus databases for studies published between January 2010 and March 2025
No Hidden or Membership Fees: Everything is included in your monthly cost (medication, care, and delivery)
GLP-1 market, with tirzepatide-based products accounting for two-thirds of all patients taking obesity medications [39]
SGLT2 inhibition alters substrate utilization and mitochondrial redox in healthy and failing rat hearts
UAE Research suggests that senescent cells impair proteasome activity in the heart, leading to the accumulation of damaged proteins and reduced cardiac function